BioCryst Pharmaceuticals Inc (BCRX)
4.24
+0.08
(+1.92%)
USD |
NASDAQ |
Apr 26, 09:59
BioCryst Pharmaceuticals Cash from Operations (TTM): -95.14M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -95.14M |
| September 30, 2023 | -110.07M |
| June 30, 2023 | -122.62M |
| March 31, 2023 | -131.56M |
| December 31, 2022 | -161.85M |
| September 30, 2022 | -170.46M |
| June 30, 2022 | -161.29M |
| March 31, 2022 | -158.95M |
| December 31, 2021 | -142.16M |
| September 30, 2021 | -152.23M |
| June 30, 2021 | -167.21M |
| March 31, 2021 | -172.84M |
| December 31, 2020 | -135.11M |
| September 30, 2020 | -103.02M |
| June 30, 2020 | -92.41M |
| March 31, 2020 | -85.87M |
| December 31, 2019 | -89.58M |
| September 30, 2019 | -103.12M |
| June 30, 2019 | -110.52M |
| March 31, 2019 | -99.91M |
| December 31, 2018 | -92.56M |
| September 30, 2018 | -79.10M |
| June 30, 2018 | -56.50M |
| March 31, 2018 | -52.27M |
| December 31, 2017 | -41.14M |
| Date | Value |
|---|---|
| September 30, 2017 | -36.48M |
| June 30, 2017 | -41.61M |
| March 31, 2017 | -43.12M |
| December 31, 2016 | -53.44M |
| September 30, 2016 | -62.41M |
| June 30, 2016 | -57.51M |
| March 31, 2016 | -28.23M |
| December 31, 2015 | -13.12M |
| September 30, 2015 | -12.18M |
| June 30, 2015 | -8.118M |
| March 31, 2015 | -33.32M |
| December 31, 2014 | -38.55M |
| September 30, 2014 | -29.18M |
| June 30, 2014 | -28.50M |
| March 31, 2014 | -24.29M |
| December 31, 2013 | -26.53M |
| September 30, 2013 | -29.04M |
| June 30, 2013 | -32.90M |
| March 31, 2013 | -36.35M |
| December 31, 2012 | -37.40M |
| September 30, 2012 | -34.35M |
| June 30, 2012 | -33.04M |
| March 31, 2012 | -30.17M |
| December 31, 2011 | -32.25M |
| September 30, 2011 | -34.09M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-172.84M
Minimum
Mar 2021
-85.87M
Maximum
Mar 2020
-129.79M
Average
-131.56M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Electromed Inc | 4.872M |
| Armata Pharmaceuticals Inc | -47.42M |